Affymetrix Reports Methods for More Accurate Examination of Circulating miRNAs | GenomeWeb

By Molika Ashford

Purification steps can remove the confounding influence of cell-based miRNAs, allowing more robust measurement of circulating miRNAs, Affymetrix researchers reported recently in a study in PLoS One.

Using the company's GeneChip miRNA microarray, the team evaluated a variety of methods to reduce the presence of cellular miRNAs in blood samples in order to allow more accurate and reproducible analysis of circulating miRNA for potential predictive signatures.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.